Entrada Therapeutics TRDA
NASDAQ TRDA
$6.35 +0.09 (+1.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) EV to FCF (2023)

Updated

Entrada Therapeutics' EV to FCF was 3.26 in Q4 2023, down 23.8% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) EV to FCF (2023) Analysis & Trends

From Q1 2023 onward, Entrada Therapeutics has reported EV to FCF for 4 quarters.

  • Quarterly EV to FCF has moved between 2.00 (Q1 2023) and 4.27 (Q3 2023) over five years.
  • Per Business Quant data, TRDA's EV to FCF in the three quarters before Q4 2023 was 4.27 (Q3 2023), 3.89 (Q2 2023) and 2.00 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Entrada Therapeutics 247.25 Mn 247.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 3.26
Sep 30, 2023 4.27
Jun 30, 2023 3.89
Mar 31, 2023 2.00
API Access

Entrada Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=TRDA&period=max&api_key=YOUR_API_KEY